These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21954141)

  • 21. Spanish translation and linguistic validation of the North Star Ambulatory Assessment for Duchenne muscular dystrophy functional evaluation.
    Medina-Cantillo J; Moya-Arcos O; Padrós-Domingo N; Roca-Urraca S; Vigo-Morancho M; Mas S
    Rev Neurol; 2021 May; 72(10):337-342. PubMed ID: 33978227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six-minute walk test versus two-minute walk test in children with Duchenne muscular dystrophy: Is more time more information?
    Vill K; Ille L; Schroeder SA; Blaschek A; Müller-Felber W
    Eur J Paediatr Neurol; 2015 Nov; 19(6):640-6. PubMed ID: 26455815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy.
    Kempen JC; Harlaar J; van der Kooi AJ; de Groot IJ; van den Bergen JC; Niks EH; Verschuuren JJ; Brehm MA
    Neuromuscul Disord; 2014 Mar; 24(3):216-21. PubMed ID: 24365209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ankle contractures and functional motor decline in Duchenne muscular dystrophy.
    Woof AL; Selby K; Harris SR
    Brain Dev; 2022 Feb; 44(2):105-113. PubMed ID: 34629214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.
    McDonald CM; Henricson EK; Abresch RT; Florence J; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz SW
    Muscle Nerve; 2013 Sep; 48(3):357-68. PubMed ID: 23674289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boys With Duchenne Muscular Dystrophy: 1-Year Locomotor Changes in Relation to a Control Group.
    Martini J; Caromano FA; Carvalho EV; Goya PA; Hayasaka RM; Nakazune S; Fávero FM; Voos MC
    Percept Mot Skills; 2018 Feb; 125(1):40-56. PubMed ID: 29171337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 100-meter timed test: Normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials.
    Alfano LN; Miller NF; Berry KM; Yin H; Rolf KE; Flanigan KM; Mendell JR; Lowes LP
    Neuromuscul Disord; 2017 May; 27(5):452-457. PubMed ID: 28279570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy.
    Mayhew AG; Moat D; McDermott MP; Eagle M; Griggs RC; King WM; James MK; Muni-Lofra R; Shillington A; Gregson S; Pallant L; Skura C; Staudt LA; Eichinger K; McMurchie H; Rabb R; Di Marco M; Brown S; Zanin R; Arnoldi MT; McIntyre M; Wilson A; Alfano LN; Lowes LP; Blomgren C; Milev E; Iodice M; Pasternak A; Chiu A; Lehnert I; Claus N; Dieruf KA; Rolle E; Nicorici A; Andres B; Hobbiebrunken E; Roetmann G; Kern V; Civitello M; Vogt S; Hayes MJ; Scholtes C; Lacroix C; Gunn T; Warner S; Newman J; Barp A; Kundrat K; Kovelman S; Powers PJ; Guglieri M;
    Neuromuscul Disord; 2022 Jun; 32(6):460-467. PubMed ID: 35618576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures.
    Lerario A; Bonfiglio S; Sormani M; Tettamanti A; Marktel S; Napolitano S; Previtali S; Scarlato M; Natali-Sora M; Mercuri E; Bresolin N; Mongini T; Comi G; Gatti R; Ciceri F; Cossu G; Torrente Y
    BMC Neurol; 2012 Sep; 12():91. PubMed ID: 22974002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revised Hammersmith Scale for spinal muscular atrophy: Inter and intra-rater reliability and agreement.
    Ramsey D; Ramdharry G; Scoto M; Muntoni F; Wallace A;
    PLoS One; 2022; 17(12):e0278996. PubMed ID: 36542615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative electromyography in ambulatory boys with Duchenne muscular dystrophy.
    Verma S; Lin J; Travers C; McCracken C; Shah D
    Muscle Nerve; 2017 Dec; 56(6):1168-1171. PubMed ID: 28457006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool.
    Scott E; Mawson SJ
    Dev Med Child Neurol; 2006 Jun; 48(6):540-4. PubMed ID: 16700951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical Activity in Boys With Duchenne Muscular Dystrophy Is Lower and Less Demanding Compared to Healthy Boys.
    Heutinck L; Kampen NV; Jansen M; Groot IJ
    J Child Neurol; 2017 Apr; 32(5):450-457. PubMed ID: 28112012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrical impedance myography in Duchenne muscular dystrophy and healthy controls: A multicenter study of reliability and validity.
    Zaidman CM; Wang LL; Connolly AM; Florence J; Wong BL; Parsons JA; Apkon S; Goyal N; Williams E; Escolar D; Rutkove SB; Bohorquez JL;
    Muscle Nerve; 2015 Oct; 52(4):592-7. PubMed ID: 25702806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy.
    Mayhew JE; Florence JM; Mayhew TP; Henricson EK; Leshner RT; McCarter RJ; Escolar DM
    Muscle Nerve; 2007 Jan; 35(1):36-42. PubMed ID: 16969838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Test-retest reliability of the Performance of Upper Limb (PUL) module for muscular dystrophy patients.
    Gandolla M; Antonietti A; Longatelli V; Biffi E; Diella E; Delle Fave M; Rossini M; Molteni F; D'Angelo G; Bocciolone M; Pedrocchi A
    PLoS One; 2020; 15(9):e0239064. PubMed ID: 32986757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Composite biomarkers for assessing Duchenne muscular dystrophy: an initial assessment.
    Shklyar I; Pasternak A; Kapur K; Darras BT; Rutkove SB
    Pediatr Neurol; 2015 Feb; 52(2):202-5. PubMed ID: 25447928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
    Tian C; Wong BL; Hornung L; Khoury JC; Miller L; Bange J; Rybalsky I; Rutter MM
    Neuromuscul Disord; 2016 Nov; 26(11):760-767. PubMed ID: 27614576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy.
    Muntoni F; Domingos J; Manzur AY; Mayhew A; Guglieri M; ; Sajeev G; Signorovitch J; Ward SJ
    PLoS One; 2019; 14(9):e0221097. PubMed ID: 31479456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.